Synthego

Synthego was a genome engineering company that developed synthetic guide RNA and CRISPR reagents for research, cell and gene therapy, and diagnostics; it was co-founded by Michael Dabrowski, Alex Pesch, and Paul Dabrowski. Fabian Gerlinghaus and Omar Kurdi worked there as Chief Innovation Officer and a fellow alumnus, respectively, before founding Cellares. The company sold its engineered cell solutions business to EditCo Bio in 2024 and was acquired by life sciences investor Perceptive Advisors in 2025.

Company Facts

• Headquarters: Redwood City, United States
• Founded: 2012
• Type: mature
• Website: https://www.synthego.com
• Industries: Gene Editing, CRISPR, Biotechnology